artemisinin has been researched along with Breast Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bez, G; Das, B; Khongsti, K; Pasupuleti, BG | 1 |
| Chen, Y; Dong, J; Li, L; Yang, W; Zhang, X | 1 |
| Keshari, S; Kumari, K; Mishra, SK; Sabat, SC; Sengupta, D | 1 |
| Cao, Y; Feng, YH; Gao, LW; Jin, F; Jin, QX; Li, XY; Lu, SL; Wang, YY; Wei, MJ; Xu, YY | 1 |
| Gallis, B; Ho, RJ; Sasaki, T; Taya, M; Wang, S; Zhang, YJ | 1 |
| Sasaki, T; Wang, S | 1 |
| Faezizadeh, Z; Gharib, A; Mesbah-Namin, SA; Saravani, R | 1 |
| Barker, GC; Lapkin, AA; Romero-Canelón, I; Suberu, JO; Sullivan, N | 1 |
| Ho, RJ; Sasaki, T; Wang, L; Zhan, X; Zhang, YJ | 1 |
| Firestone, GL; Hargraves, KG; He, L | 1 |
| Doan, VB; Firestone, GL; Marconett, CN; Sundar, SN; Willoughby, JA | 1 |
| Firestone, GL; Park, AH; Poindexter, KM; Sundar, SN; Tin, AS; Tran, KQ | 1 |
| Ma, J; Wang, J; Wang, X; Wang, Z; Yu, Y; Zhang, H; Zhang, Q; Zhang, X | 1 |
| Gallis, BM; Gong, Y; Goodlett, DR; Lacoste, E; Lai, H; Lu, H; Sasaki, T; Yang, Y | 1 |
| Garga, NI; Panossian, LA; Pelletier, D | 1 |
| Lai, H; Singh, NP | 1 |
| Ahmed, MS; El-Feraly, FS; ElSohly, HN; ElSohly, MA; Galal, AM; McPhail, AT; Ross, SA | 1 |
17 other study(ies) available for artemisinin and Breast Neoplasms
| Article | Year |
|---|---|
1,2,3-Triazole tethered 1,2,4-trioxanes: Studies on their synthesis and effect on osteopontin expression in MDA-MB-435 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds; Humans; Molecular Structure; Osteopontin; Structure-Activity Relationship; Triazoles | 2020 |
Antitumor and anti-angiogenic effects of artemisinin on breast tumor xenografts in nude mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Artemisinins; Breast Neoplasms; Down-Regulation; Female; Heterografts; Mice; Mice, Inbred BALB C; Mice, Nude | 2020 |
Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Breast Neoplasms; Cell Movement; Cell Proliferation; Cell Survival; Epigenesis, Genetic; Female; Gene Expression Profiling; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; MCF-7 Cells; Neoplasm Invasiveness; Oncogenes; Transcriptome | 2017 |
Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Topics: Animals; Apoptosis; Artemisinins; Breast Neoplasms; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Immunity, Cellular; Immunization; Interferon-gamma; Lymphocyte Activation; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; T-Box Domain Proteins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 2019 |
pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.
Topics: Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Liposomes; Nanoparticles; Receptor, ErbB-2 | 2013 |
Synthesis of artemisinin dimers using the Ugi reaction and their in vitro efficacy on breast cancer cells.
Topics: Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimerization; Female; Humans | 2013 |
Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.
Topics: Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Female; Ferric Compounds; Humans; Liposomes; Magnetic Phenomena; MCF-7 Cells; Nanostructures; Particle Size; Temperature; Transferrin | 2014 |
Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells.
Topics: Artemisia; Artemisinins; Breast Neoplasms; Cell Survival; Chlorogenic Acid; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Plant Extracts | 2014 |
pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.
Topics: Animals; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Dimerization; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Lipids; Mice; Mice, Nude; Nanoparticles; Treatment Outcome; Xenograft Model Antitumor Assays | 2015 |
Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Artemisinins; Artesunate; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; MCF-7 Cells; MicroRNAs; Tumor Suppressor Protein p53 | 2016 |
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
Topics: Antineoplastic Agents; Artemisinins; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Female; Flow Cytometry; Gene Expression; Humans; Immunoprecipitation; Promoter Regions, Genetic; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2008 |
Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Topics: Animals; Antineoplastic Agents; Artemisinins; Breast Neoplasms; Cell Line, Tumor; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; E2F1 Transcription Factor; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2012 |
LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Endothelial Cells; Female; Fluorescent Dyes; Humans; Kinetics; Lymphatic System; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Peptides, Cyclic; Polyesters; Polyethylene Glycols; Polymers | 2012 |
Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.
Topics: Apoptosis; Artemisinins; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Humans; Inhibitor of Apoptosis Proteins; Male; Prostatic Neoplasms; Protein Multimerization; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Survivin; Transferrin; Wnt Signaling Pathway | 2013 |
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer.
Topics: Adult; Anti-Infective Agents; Artemisinins; Brain Stem; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Sesquiterpenes | 2005 |
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Anti-Infective Agents; Artemisinins; Breast Neoplasms; Carcinogens; Chemoprevention; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Animal; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2006 |
Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation.
Topics: Antineoplastic Agents, Phytogenic; Artemisia; Artemisinins; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Oxidation-Reduction; Oxygen; Photochemistry; Saudi Arabia; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |